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Living  with  a  visible  difference  can  entail  challenging  social  situations,  associated  with  psychosocial
symptoms.  However,  it is  not  clear  whether  adolescents  with  a visible  difference  experience  more  anx-
iety and  depression  than  unaffected  peers.  We  aim  to determine  whether  adolescents  with  a visible
difference  experience  more  symptoms  of  anxiety  and  depression  than  unaffected  peers.  A literature
search  was  conducted  in Embase,  Medline  Ovid,  Web  of  Science,  Cochrane  CENTRAL,  PsycINFO  Ovid,
and  Google  Scholar.  Meta-analyses  were  done  using  random-effects  models  to calculate  a standardised
mean  difference.  Analyses  for subgroups  were  used  to study  causes  of  visible  difference.  Eleven  studies
were  identified  (n = 1075,  weighted  mean  age  = 15.80).  Compared  to  unaffected  peers,  adolescents  with
a  visible  difference  experience  more  symptoms  of  anxiety  (SMD  =  0.253,  95  % CI [0.024,  0.482], p =  .030),
but  not  depression  (SMD  =  0.236,  95  %  CI [−0.126,  0.599],  p =  .202).  Adolescents  with  a skin  condition  did
not  experience  more  symptoms  of  anxiety  (SMD = 0.149,  95  % CI  [−0.070,  0.369],  p  = .182)  or depression
(SMD  =  0.090,  95  % CI [−0.082,  0.262],  p =  .305)  when  compared  to unaffected  peers.  Overall,  more  symp-
toms  of  anxiety  are  found  in adolescents  with  a visible  difference  compared  to  peers.  No  differences  in
anxiety  or  depression  were found  for  skin  differences.  Screening  for anxiety  is recommended.
©  2020  Published  by Elsevier  Ltd.. Introduction
Approximately 1 in 44 people have a condition or injury that
esults in a socially undesirable impact on their physical appear-
nce (Changing Faces, 2010). These appearance altering conditions
re often referred to as a visible difference or disfigurement and
an result from congenital conditions (e.g., cleft lip and palate,
raniofacial conditions), skin conditions (e.g., vitiligo, psoriasis and
cne), trauma (e.g., burns, scars), disease (e.g., cancer, meningitis
∗ Corresponding author.
E-mail address: j.okkerse@erasmusmc.nl (J.M.E. Okkerse).
ttps://doi.org/10.1016/j.bodyim.2020.02.006
740-1445/© 2020 Published by Elsevier Ltd.and alopecia areata) or medical treatment (e.g., surgery or radio-
therapy). The term visible difference is a relatively new term, with
the first mention in the literature occurring in 2004 (Rumsey et al.,
2004).
One important aspect in visible differences is negative observer
responses. Having a visible difference can lead to challenging social
situations and negative observer responses, such as staring, teasing,
and receiving unwanted comments (Jewett et al., 2018; Masnari
et al., 2012). These experiences can be distressing, and individuals
often develop a fear of being negatively evaluated based on their
appearance (Kent & Keohane, 2001). This can result in avoidance
of social activities such as going to parties, participating in sports
and appearing in photos (Rumsey, Clarke, White, Wyn-Williams,
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adolescence was done. A research librarian conducted a search
using Embase, Medline Ovid, Web  of Science, Cochrane CENTRAL,
PsycINFO Ovid, and Google Scholar. The search was  conducted inM. van Dalen et al. / B
 Garlick, 2004). Concerns around developing romantic relation-
hips can also greatly impact self-esteem in adolescents and adults
ith a visible difference (Griffiths, Williamson, & Rumsey, 2012).
urthermore, a study by Moss (2005) shows that the severity of the
isible difference is not directly related to the amount of psycholog-
cal distress. Rather, the subjective severity of the visible difference
redicts psychological distress.
A possible consequence of negative observer responses are
ymptoms of anxiety and depression. In the general population,
nxiety and depression are the second and third most common dis-
rders in adolescence (Costello, Copeland, & Angold, 2011) and are
hus considered a major cause for mental health-related disability.
 review of prevalence rates shows a mean prevalence of 10.7 % for
nxiety and 6.1 % for depressive disorders in adolescence (Costello
t al., 2011). However, 12-month prevalence rates as high as 8.2
 for depression and 24.9 % for anxiety in adolescence have been
eported (Kessler et al., 2012). Also, prevalence rates of depression
nd anxiety disorders seem to increase throughout childhood and
dolescence (Copeland, Angold, Shanahan, & Costello, 2014; Ford,
oodman, & Meltzer, 2003), with girls experiencing more anxi-
ty and depression (Wesselhoeft, Sørensen, Heiervang, & Bilenberg,
013). Being diagnosed with an anxiety or depressive disorder in
hildhood can also have implications for adulthood. For instance,
tudies show that depression in adolescence predicts depression
n adulthood, as do some types of anxiety disorders (Copeland,
hanahan, Costello, & Angold, 2009).
Another important aspect of visible differences in adolescence
s body image. Body dissatisfaction, the discrepancy between the
erceived body shape and the ideal body shape, is very com-
on  in adolescence (Dion et al., 2015). In their study, Dion et al.
2015) found that in underweight girls, 62.5 % of girls were sat-
sfied with their body shape. For all other weight categories, the
roportion of adolescents satisfied with their body shape ranged
rom 39.2 % to 0%. So, the majority of adolescents experience
ody dissatisfaction. Body dissatisfaction has been shown to be
elated to negative psychosocial outcomes, such as (social) anx-
ety in adolescents (Vannucci & Ohannessian, 2017) and college
omen (Fitzsimmons-Craft & Bardone-Cone, 2012). Furthermore, a
reater body image disturbance, body dissatisfaction, body impor-
ance, and body change strategies to increase muscularity, sex, and
tress have all been linked to depressive symptoms in adolescence
Flores-Cornejo, Kamego-Tome, Zapata-Pachas, & Alvarado, 2017;
urray, Rieger, & Byrne, 2018).
Literature assessing body image in visible differences is mixed.
or adolescents with craniofacial conditions, body image seems to
e similar to non-affected peers (Crerand, Sarwer, Kazak, Clarke, &
umsey, 2017). On the other hand, adolescents with acne experi-
nce a poorer body image when compared to peers (Dalgard, Gieler,
olm, Bjertness, & Hauser, 2008). When adults with a visible dif-
erence are compared to adults with an invisible mental illness, the
ormer group experiences a more positive body image (Shpigelman
 HaGani, 2019), indicating that a nonvisible condition might be
ssociated with a poorer body image than a visible condition. In
um, a poor body image is related to anxiety and depression. How-
ver, it remains debatable whether the body image of adolescents
ith a visible difference is negatively affected by their appearance.
In a European survey concerning visible difference, 116 psy-
hosocial specialists from 15 countries reported that up to 83 %
f their referrals for adolescents with a visible difference were
elated to social anxiety and up to 79 % of referrals were related
o depressed mood (Harcourt et al., 2018). In an adult sample of
58 persons with a visible difference from 15 outpatient clinics
n the United Kingdom, 48 % experienced subclinical or clinical
ymptoms of anxiety and up to 27.5 % experienced subclinical or
linical symptoms of depression (Rumsey et al., 2004). In this study,
ersons attending burns, eye, and hand clinics had the lowest anx-age 33 (2020) 38–46 39
iety scores, while persons seeking elective plastic surgery had the
highest anxiety scores. Furthermore, hand patients had the lowest
depression scores, while persons seeking elective plastic surgery
had the highest depression scores.
When looking at symptoms of anxiety and depression in ado-
lescents, studies are inconsistent. Studies have either reported no
significant differences between adolescents with a visible differ-
ence and unaffected peers (e.g., Aktan, Özmen, & S¸ anli, 2000; Pope,
Solomons, Done, Cohn, & Possamai, 2007) or significantly more
anxiety and depressive symptoms in adolescents with a visible dif-
ference when compared to unaffected peers (e.g., Hon et al., 2015;
Rivlin & Faragher, 2007).
In sum, depression and anxiety are common psychological dis-
orders. However, due to inconsistent findings, the question of
whether adolescents with a visible difference experience more anx-
iety and depressive symptoms than unaffected peers has not been
systematically explored. Therefore, the aim of the current meta-
analysis is (1) to determine whether adolescents (12–18 years old)
with a visible difference suffer more symptoms of anxiety and
depression than unaffected peers and (2) to determine the influ-
ence of the cause of visible difference on anxiety and depression in
these adolescents.
This meta-analysis can contribute to the knowledge regarding
the psychosocial impact of having a visible difference. To date, it is
not known whether adolescents with a visible difference resulting
from a wide variety of conditions and injuries, present with the
same psychosocial symptoms, or whether this differs by cause of
visible difference.
2. Method
This meta-analysis was  performed according to the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement (Moher, Liberati, Tetzlaff, & Altman, 2009).
The meta-analysis was  registered prospectively in the international
prospective register of systematic reviews, PROSPERO, registration
number CRD42018110201.
2.1. Eligibility criteria
Studies were included if they met  the following eligibility cri-
teria: (a) sample with a mean age between 12 and 18, (b) sample
with a visible difference, (c) quantitative data on anxiety and/or
depression from a validated questionnaire, (d) data reported by
adolescents or parents, and (e) a control group of unaffected peers.
Studies were excluded if (a) they were published in a non-English
language, (b) they reported on a sample with cognitive develop-
mental delay, (c) they reported on a traumatic event less than three
months before the study (e.g., studies on psychological well-being
in burn victims with burns sustained less than three months before
were excluded),1 (d) the visible difference was caused by self-
harming, and (e) they described case reports, case series, qualitative
studies, dissertations or review papers, and conference abstracts.
2.2. Information sources and search
As there was  no clear picture on how many articles a search
solely on anxiety and depression would yield, a broader search
focusing on social and emotional aspects of visible differences in1 After this period, potential post-traumatic stress symptoms will have declined
(Hiller et al., 2016).
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une 2018 and updated in February and April 2019. The search
ncluded terms relating to visible difference or disfigurement
nd the following relevant medical conditions: neurofibromato-
is, limb malformation, eczema, psoriasis, epidermolysis bullosa,
itiligo, skin haemangioma, albinism, port-wine stains, ectodermal
ysplasia, scars, stoma, wheelchair, amputation, burns, paraly-
is, hirsutism, cerebral palsy, craniofacial malformations, and cleft
ip. These terms were combined with terms relating to anxiety
nd depression, and adolescence. The search excluded conference
bstracts, letters and editorials, and was limited to articles writ-
en in English. The full search is displayed in the Supplementary
aterial.
.3. Study selection
Studies were selected if they met  the inclusion criteria. First,
wo reviewers (MvD and YK or FH) independently assessed title and
bstract. The reviewers agreed on 88.6 % of the references. Discrep-
ncies were resolved using consensus. Second, two reviewers (MvD
nd YK or FH) independently assessed the full text for eligibility.
eviewer agreement was 90.0 % for the second step. Discrepancies
ere again resolved using consensus. Third, MvD  checked the ref-
rence list of included articles for additional relevant references.
ny references deemed relevant were first screened based on title
nd abstract. If still relevant, the full-text was read. When the arti-
le met  the inclusion and exclusion criteria, it was  included in the
eview. Endnote X9 was used to manage references.
.4. Data collection process and data items
Data collection was completed independently by two  reviewers
MvD and YK), using a data extraction form. The following data were
xtracted: year of publication, medical condition involved, sample
ize, percentage male, mean age of the sample, age range, mean
core, and standard deviation.
.5. Quality and risk of bias
Quality and risk of bias were assessed using the NIH Quality
ssessment for Observational Cohort and Cross-sectional studies
National Heart Lung & Blood Institute (NIH), 2018). This check-
ist includes 14 questions with yes,  no or cannot determine/not
eported/not applicable responses. For cross-sectional studies, only
 questions are applicable. Hence, we rated 5.5–7 (>80 %) points as
ood, 4.5 or 5 (60–80 %) points as fair and 4 points or less (<60 %)
s poor quality. Quality assessment was performed independently
y two reviewers (MvD and YK). Discrepancies were resolved by
onsensus.
.6. Data synthesis and statistical analyses
Comprehensive Meta-Analysis (CMA), version 2 was  used for
eta-analysis. Because of the high likelihood of between-study
eterogeneity, a random-effects model was employed. Means and
tandard deviations of the samples were used to compute an effect
ize, the standardized mean difference (SMD). When means and
tandard deviations were not available, medians were transformed
o means and SDs using the interquartile range, as described by
an, Wang, Liu, and Tong (2014).
Separate meta-analyses were conducted for anxiety and depres-
ion, using the SMD  as effect measure. Heterogeneity was  assessed
sing the I2-statistic, with values ≥75 % indicating considerable het-
rogeneity (Melsen, Bootsma, Rovers, & Bonten, 2014). Publication
ias was assessed by visual inspection of a funnel plot and Egger’s
egression. To assess whether cause of visible difference influencedage 33 (2020) 38–46
the results (Aim 2), analyses for subgroups were performed. Sub-
groups were defined based on the cause of visible difference: (1)
congenital conditions, (2) skin conditions, (3) trauma, (4) disease,
or (5) medical treatment. When two  or more studies were present
in a subgroup, a meta-analysis for the subgroup was conducted.
3. Results
3.1. Study selection
After removing duplicate articles, the database search yielded
4764 records. One additional record was  identified through the ref-
erence lists of included articles. The title/abstract was screened in
all 4765 records, 4098 articles did not meet the inclusion crite-
ria. Thereafter 676 full-text articles were assessed for eligibility, of
which 147 records met  the inclusion criteria and focussed on social
and emotional aspects of a visible difference. Of the 147 articles
focusing on social and emotional aspects of a visible difference, 11
were included in the meta-analyses. Of the 136 articles excluded,
most did not focus on anxiety and/or depression (n = 91). Fig. 1
details the selection process.
3.2. Study characteristics
Eleven studies were included in the meta-analyses, as displayed
in Table 1. These studies included a total of 1075 adolescents with
a visible difference and 2375 unaffected peers. Of  the adolescents
with a visible difference, 47.61 % were male. Of the unaffected
peers, 44.82 % percent were male. One study included females only
(Drosdzol, Skrzypulec, & Plinta, 2010). The number of adolescents
with a visible difference per study ranged from 15 to 385, with
a median sample size of 44. The weighted mean age was  15.80.
One study did not report a mean age (Turan et al., 2015). The
youngest participants were 7 years old, the oldest 20 years old. Six
studies investigated a skin condition (acne, vitiligo, alopecia, hir-
sutism, and atopic eczema), two investigated a congenital condition
(cleft lip or cleft lip and palate [CL/P] and neurofibromatosis type 1
[NF1]), two investigated a visible difference due to trauma (burns),
and one investigated a visible difference due to disease (cutaneous
leishmaniasis). All studies included self-report measures, and none
included parent or proxy reports.
3.3. Study quality/risk of bias
The quality assessment is shown in Table 2. The mean qual-
ity score was  3.59 (range 1.0–6.0), which can be considered poor
quality. Overall, eight studies were considered to be of poor qual-
ity (Aktan et al., 2000; Bilgic¸ et al., 2014; Díaz-Atienza & Gurpegui,
2011; Feragen, Stock, Sharratt, & Kvalem, 2016; Hon et al., 2015;
Pasini et al., 2012; Pope et al., 2007; Rivlin & Faragher, 2007).
Two studies were of fair quality (Bilgic¸ , Bilgic¸ , Akis¸ , Eskiogˇlu, &
Kilic¸ , 2011; Turan et al., 2015) and one study was of good quality
(Drosdzol et al., 2010). None of the studies achieved a maximum
score of seven points.
3.4. Anxiety symptoms
A meta-analysis was  run to estimate whether adolescents with a
visible difference experience more symptoms of anxiety than unaf-
fected peers. Nine studies reported on symptoms of anxiety (Aktan
et al., 2000; Bilgic¸ et al., 2011, 2014; Díaz-Atienza & Gurpegui, 2011;
Drosdzol et al., 2010; Hon et al., 2015; Pasini et al., 2012; Rivlin &
Faragher, 2007; Turan et al., 2015), with five different instruments.
The studies included 653 participants, with a weighted mean age
of 15.45, and 526 controls. One study did not report a mean age
(Turan et al., 2015).
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Table 1
Overview of study characteristics.
Study Type of condition Condition % male Mean age (range) Quality score Outcome Instrument
Visible difference Healthy controls
Sample
size
Mean SD Sample
size
Mean SD
Aktan et al. (2000) Skin condition Acne vulgaris 67.6 16.1 (14–20) 2.5
Anxiety HADS
308
8.00 4.05
308
7.62 4.34
Depression HADS 4.54 2.82 4.73 2.82
Bilgic¸ et al. (2011) Skin condition Vitiligo 44.0 15.72 (13–18) 6.0
Anxiety STAI-C: trait
anxiety 25
37.16 6.93
26
36.46 5.83
Depression CDI 12.76 7.99 12.04 7.33
Bilgic¸ et al. (2014) Skin condition Alopecia areata 61.8 14.6 (13–18) 4.5
Anxiety STAI-C: trait
anxiety 34
35.60 6.80
32
35.20 6.00
Depression CDI 11.50 7.00 10.50 7.20
Díaz-Atienza and
Gurpegui (2011) Skin condition
Alopecia areata 52.0 12.2 (7–19) 3.0
Anxiety STAI-C: trait
anxiety 31
12.20 6.90
25
15.00 7.50
Depression CDI 9.80 5.30 9.70 4.70
Drosdzol et al. (2010) Skin condition Hirsutism 0 16.44 (13–18) 5.0
Anxiety HADS
50
5.00* 3.82*
50
3.00* 3.05*
Depression HADS 2.17* 3.82* 1.50* 2.29*
Feragen et al. (2016) Congenital Cleft lip (and palate) 60.2 16 (16) 4.0 Depression HSCL-7 385 1.46 0.43 1808 1.75 .57
Hon et al. (2015) Skin condition Atopic eczema 58.0 16.0 (14.4–18.2) 1.0
Anxiety DASS-42
120
4.67* 4.50*
26
3.33* 2.35*
Depression DASS-42 3.67* 5.25* 1.33* 3.14*
Pasini et al. (2012) Congenital NF1 33.3 13.4 (9–18) 3.0 Anxiety MASC 15 48.90 7.00 15 40.70 6.40
Pope et al. (2007) Trauma Burns 36.1 15.1 (11–19) 2.5 Depression BDI-II 36 10.37 9.73 41 10.10 7.92
Rivlin and Faragher (2007) Trauma Burns 50.0 13.5 (9–16) 3.5 Anxiety Short form -
MAS
44 6.55 3.35 24 4.55 3.30
Turan et al. (2015) Disease
Cutaneous
leishmaniasis
53.7 NR (13–18) 4.5
Anxiety STAI-C: trait
anxiety
54 36.41 40.50 20 33.90 10.87
Depression CDI 14.25 4.76 4.50 2.46
Note. NR, Not reported; NF1, Neurofibromatosis type 1; BDI, Beck Depression Inventory; CDI, Children’s Depression Inventory; DASS-42, Depression Anxiety Stress Scale - 42; HADS, Hospital Anxiety and Depression Scale; HSCL-7,
the  Hopkins Symptoms Checklist - 7; MASC, Multidimensional Anxiety Scale for Children; short form-MAS, short form Manifest Anxiety Scale; STAI-C, State Trait Anxiety Inventory for Children. * Scores calculated using the
method  described by Wan  et al. (2014).
42 M. van Dalen et al. / Body Image 33 (2020) 38–46
Fig. 1. Flow chart displaying the selection process.
Table 2
Quality assessment of included studies.
1. Research
question
2. Study
population
3. Partici-
pation
rate
4. Recruitment 5. Power 6. Outcome
measures
7.  Confounders Total score
Aktan et al. (2000) 1 0.5 CD 0 0 1 NR 2.5
Bilgic¸ et al. (2011) 1 1 1 1 0 1 NR 5
Bilgic¸ et al. (2014) 1 0.5 CD 0.5 0 1 1 4
Díaz-Atienza and Gurpegui
(2011)
1 1 CD 0.5 0 1 NR 3.5
Drosdzol et al. (2010) 1 1 1 1 0 1 NR 6
Feragen et al. (2016) 1 1 1 0 0 1 NR 4
Hon et al. (2015) 0.5 0 CD CD 0 0.5 NR 1
Pasini et al. (2012) 1 0.5 CD 0 0 1 NR 2.5
Pope et al. (2007) 1 0.5 1 CD 0 1 0.5 4
Rivlin and Faragher (2007) 0.5 0.5 0 1 0 1 0.5 3.5
Turan et al. (2015) 1 1 CD 0.5 0 1 1 4.5
Note. CD: Cannot Determine; NR: Not Reported. 1. Was  the research question or objective in this paper clearly stated? 2. Was  the study population clearly specified and
defined? 3. Was  the participation rate of eligible persons at least 50 %? 4. Were all subjects selected or recruited from the same or similar populations? Were inclusion
and  exclusion criteria for being in the study prespecified and applied uniformly to all participants? 5. Was  a sample size justification, power description, or variance and
effect  estimates provided? 6. Were the exposure outcome measures clearly defined, valid, reliable and implemented consistently across all study participants? 7. Were key
potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure and outcome?
M. van Dalen et al. / Body Image 33 (2020) 38–46 43
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ote. 1. Visible difference due to skin disease; 2. Congenital visible difference; 3. Visi
ype  1.
Fig. 2 shows the meta-analysis for anxiety. Results show that
dolescents with a visible difference experience significantly more
nxiety than unaffected peers (SMD = 0.253, 95 % CI [0.024, 0.482],
 = .030), with a small effect size. Some level of heterogeneity
as observed (I2 = 59.55 %, p = .011). Inspection of the funnel plot
ndicated a symmetric funnel plot, with Egger’s regression being
on-significant, t(7) = 1.10, p = .307. This indicates an absence of
ublication bias.
Meta-analysis for subgroups of visible differences showed that
dolescents with a skin condition did not differ significantly from
naffected peers (SMD = 0.149, 95 % CI [−0.070, 0.369], p = .182).
here was no significant heterogeneity (I2 = 47.76 %, p = .088). The
unnel plot showed a symmetric shape.
Meta-analyses for subgroups could only be run for skin condi-
ions, as only one study investigated a congenital condition (NF1;
asini et al., 2012), one study investigated trauma (burns; Rivlin &
aragher, 2007) and one study investigated a disease (cutaneous
eishmaniasis; Turan et al., 2015). These studies showed that ado-
escents with a congenital visible difference (SMD = 1.223, 95 % CI
0.443, 2.002], p = .002) and a visible difference due to trauma (SMD
 0.600, 95 % CI [0.093, 1.108], p = .020) experienced more anxiety
han unaffected peers. Adolescents with a visible difference due
o disease did not experience more anxiety (SMD = 0.079, 95 % CI
−0.495, 0.653], p = .788).
.5. Depressive symptoms
A meta-analysis was run to estimate whether adolescents with
 visible difference experience more depressive symptoms than
eers. Nine studies reported on depressive symptoms (Aktan et al.,
000; Bilgic¸ et al., 2011, 2014; Díaz-Atienza & Gurpegui, 2011;
rosdzol et al., 2010; Feragen et al., 2016; Hon et al., 2015; Pope
t al., 2007; Turan et al., 2015), with five different instruments. The
tudies included 1017 participants, with a weighted mean age of
5.84, and 2336 controls.Fig. 3 shows the meta-analysis for depression. Results showed
hat adolescents with a visible difference did not experience
ignificantly more depressive symptoms than unaffected peers
SMD = 0.236, 95 % CI [−0.126, 0.599], p = .202). A high level of het-fference due to trauma; 4. Visible difference due to disease; NF1, Neurofibromatosis
erogeneity was  observed (I2 = 92.19 %, p < .001). The funnel plot was
asymmetric, with more studies reporting a positive result. Egger’s
regression was  significant, indicating publication bias, t(7) = 3.51,
p = .010. The funnel plot showed one outlier (Turan et al., 2015).
Removal of this outlier resulted in a considerable decrease of the
effect size (SMD = 0.018, 95 % CI [−0.267, 0.303], p = .902). Hetero-
geneity was  still high (I2 = 86.78 %, p < .001).
Meta-analysis for subgroups based on cause of visible difference
showed that adolescents with a skin condition did not experience
significantly more depressive symptoms than unaffected peers
(SMD = 0.090, 95 % CI [−0.082, 0.262], p = .305). There was  no sig-
nificant heterogeneity (I2 = 23.79 %, p = .255).
Meta-analyses for subgroups were not run for visible difference
due to disease (cutaneous leishmaniasis), congenital conditions
(CL/P) or trauma (burns), as these categories included only one
study each. These studies show that adolescents with a visible dif-
ference due to disease (SMD = 2.453, 95 % CI [1.698, 3.208], p < .001)
experience more depressive symptoms than unaffected peers. Ado-
lescents with a congenital condition experience fewer depressive
symptoms than unaffected peers (SMD = −0.535, 95 % CI [−0.646,
−0.424], p < .001). Adolescents with a visible difference due to
trauma do not differ from unaffected peers concerning depressive
symptoms (SMD = 0.031, 95 % CI [−.417, .478], p = .893).
4. Discussion
In this meta-analysis we  compared adolescents with a visible
difference to unaffected peers and looked at different causes of
visible difference.
Our first research question asked whether adolescents with
a visible difference experience more symptoms of anxiety and
depression than unaffected peers. Results showed that this was
true for anxiety but not for depression. For anxiety a small effect
size was  found, indicating slightly elevated anxiety for adolescents
with a visible difference. For depression, a non-significant result
was found.
The results found for depression seem to be largely driven by
Turan et al. (2015), reporting an extraordinary effect size of 2.453.
As anxiety and depression are often seen as comorbid conditions
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Cummings, Caporino, & Kendall, 2014), it is noteworthy that when
ooking at symptoms of anxiety, the same study does not seem
o find any effect, with an effect size of 0.079. However, in their
tudy they note a mean of 36.41 with a standard deviation of 40.50
or adolescents with cutaneous leishmaniasis, and a mean of 33.90
ith a standard deviation of 10.87 for controls. Given that the possi-
le range of the STAI-C is 20–80, these results seem highly unlikely.
urthermore, Turan et al. (2015) have reported a p-value of .143,
hile the same results in our meta-analysis yield a p-value of .788.
his is a striking and remarkable difference. Without this outlier,
he effect for depression is not significant (SMD = 0.018, p = .902).
Our second research question concerned the effect of the cause
f visible difference on symptoms of anxiety and depression. Due to
he small number of studies found, we were only able to determine
he effects of skin conditions on anxiety and depression. Results
howed that adolescents with a skin condition did not differ in
ymptoms of anxiety and depression when compared to unaffected
eers. Both analyses included 568 adolescents with a visible dif-
erence, gathered from six different studies and five different skin
onditions. A retrospective power calculation following guidelines
s proposed by Valentine, Pigott, and Rothstein (2010) shows that
oth analyses were underpowered. Hence, we cannot firmly say
hat the lack of a significant finding is free of type II errors.
The finding that adolescents with a skin difference do not expe-
ience more anxiety than unaffected peers, while the overall group
f adolescents with a visible difference does experience more anx-
ety than unaffected peers is striking. A direct comparison of the
ifferent causes of visible differences is not possible, due to the low
mount of studies available. However, a possible explanation may
e that a selection bias has influenced the results. Most participants
ith skin conditions included in the current meta-analysis experi-
nce acne or eczema. These are conditions that often have a mild
resentation. For instance, only 6.5 % of adolescents with eczema
ave severe eczema (Silverberg & Simpson, 2014) and moderate to
evere acne vulgaris is reported in only 15–20 % of young people
ith acne (Bhate & Williams, 2013). Similarly, articles included inhe current meta-analysis reported few participants with a severe
ondition. For example, severe acne was found in only 2.1 % of
dolescents with acne (Aktan et al., 2000). It could be that the rel-difference due to trauma; 4. Visible difference due to disease; CL/P, Cleft lip and/or
atively mild symptoms of the condition have a low impact on the
psychosocial well-being of the adolescents studied.
When looking at the different subgroups, it is notable that the
results for congenital visible difference are divergent. The congeni-
tal condition NF1 shows a big effect (SMD = 1.223) with adolescents
with NF1 experiencing more symptoms of anxiety than unaffected
peers. The congenital condition CL/P shows the opposite effect
(SMD = − 0.535), with unaffected peers experiencing more depres-
sion than adolescents with CL/P. Conclusions pertaining congenital
visible difference are hard to make. More research on psychologi-
cal problems in congenital visible difference is needed to examine
how this group compares to unaffected peers.
The current results provide insight into symptoms of anxiety
and depression in adolescents with a visible difference. However,
this meta-analysis does not provide insight into the cause of these
findings. One possible explanation might lie in the social situa-
tions experienced by adolescents with a visible difference. Different
studies show that people with a visible difference commonly expe-
rience adverse social experiences (Jewett et al., 2018; Masnari et al.,
2012). These social situations might be experienced as stigmatis-
ing. Stigmatisation, in turn, has been shown to affect quality of life
and psychological adjustment in children with a facial difference
(Masnari et al., 2013). Furthermore, a relation exists between stig-
matisation and poorer mental health (Mak, Poon, Pun, & Cheung,
2007). Following this line of reasoning, adverse social experiences
might lead to psychological problems. In support of this, studies
have found higher levels of social anxiety in adults with a visible
difference (Clarke, Newell, Thompson, Harcourt, & Lindenmeyer,
2014), but more research is needed to warrant a definite conclusion.
Another possible explanation is that adolescents with a visi-
ble difference often have a chronic medical condition. Anxiety and
depression are reported to occur regularly in chronically-ill chil-
dren and adolescents (Jones et al., 2017; Pao & Bosk, 2011). In adults,
chronic medical conditions are also associated with occurrence
of major depressive disorder and anxiety disorders (Vancampfort,
Koyanagi, Hallgren, Probst, & Stubbs, 2017). The increased symp-
toms of anxiety we  found might thus be related to the underlying
medical condition instead of the visible difference itself.
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For medical practitioners, we recommend them to pay atten-
ion to the psychological aspects of dealing with a visible difference.
ore specifically, questions should be asked as to whether the ado-
escent experiences anxiety. Furthermore, it could be beneficial to
creen all adolescents with a visible difference on symptoms of
nxiety prior to their medical appointment, using computerised
uestionnaires. During the appointment, the medical practitioner
ould then enquire about the anxiety symptoms. In this way,
dolescents that are in need of extra psychological care may  be
dentified. Early intervention would then be possible and later
dverse outcomes may  be reduced. For those delivering psycho-
ogical care, we recommend focusing on anxiety when determining
he psychological burden of dealing with a visible difference. More
esearch is needed to establish the cause of anxiety in adolescents
ith a visible difference, but treatment could focus on the role of
egative observer responses and body image in the aetiology of the
sychological complaints.
This study also has some strengths and limitations. A particular
trength of this study is the thorough literature search conducted.
s it was a broad literature search, articles that were not indexed
y the terms anxiety or depression might still have been found in
he search.
However, despite the extensive literature search conducted,
nly 11 articles could be included in this meta-analysis. In com-
ination with the relatively high heterogeneity, interpretation of
urrent results should be made with caution. The results that have
een found in this study might not generalise to the entire popula-
ion of adolescents with a visible difference. Another limitation is
hat the studies included in the meta-analyses did not focus specif-
cally on visible difference, with the exception of Feragen et al.
2016). We included medical conditions that are presumed to be
ssociated with a visible difference, but it was impossible to check
hether a visible difference existed. Hence, confounders may  have
nfluenced the results.
Following these limitations, future research should study anx-
ety and depression in adolescents with a visible difference more
xtensively. To provide a clear picture on the symptoms of anxiety
nd depression, future studies should include a bigger sample size
nd use questionnaires as well as clinical interviews. Furthermore,
o directly compare the causes of visible differences, efforts should
e made to study all causes of visible differences in one sample.
hese results could help to gain insight into whether the clinical
resentation of symptoms differs depending on the cause.
In conclusion, this meta-analysis shows that adolescents with
 visible difference experience more symptoms of anxiety, but
ot depression when compared to unaffected peers. It is not yet
lear how different causes of visible difference influence symp-
oms of anxiety and depression. Future research is needed to further
xamine anxiety and depression in adolescents with a visible dif-
erence.
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